Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury-Reference-Cited by-同舟云学术

Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury

Published:2015-07-23 Issue:3 Volume:62 Page:887-899
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kim Seung-Hyun¹²,Saide Katy¹,Farrell John¹,Faulkner Lee¹,Tailor Arun¹,Ogese Monday¹,Daly Ann K.³,Pirmohamed Munir¹⁴,Park B. Kevin¹,Naisbitt Dean J.¹

Affiliation:

1. MRC Center for Drug Safety Science, Department of Molecular and Clinical Pharmacology; The University of Liverpool; Liverpool United Kingdom

2. Department of Allergy and Clinical Immunology; Ajou University School of Medicine; Suwon Korea

3. Institute of Cellular Medicine; Newcastle University, Medical School, Newcastle upon Tyne; United Kingdom

4. The Wolfson Center for Personalized Medicine, Department of Molecular and Clinical Pharmacology; The University of Liverpool; Liverpool United Kingdom

Funder

Medical Research Council

Publisher

Wiley

Subject

Hepatology

Reference34 articles.

1. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset;Fontana;Gastroenterology,2014

2. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin;Daly;Nat Genet,2009

3. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis;Kindmark;Pharmacogenomics J,2008

4. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury;Singer;Nat Genet,2010

5. HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer;Spraggs;J Clin Oncol,2011

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single cell omics in tracing cellular heterogeneity of drug-induced liver injury: technological landscape and prospective application;hLife;2024-01

2. Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals;Expert Opinion on Drug Metabolism & Toxicology;2023-11-28

3. DRUG-INDUCED LIVER INJURY: MECHANISMS, METHODS FOR PRE-CLINICAL ASSESSMENT, AND A MEDICINAL CHEMIST’S PERSPECTIVE;Medicinal Chemistry Reviews;2023-11-16

4. Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐desmethyl naproxen metabolite but not the acyl glucuronide;Allergy;2023-07-29

5. What’s been Hapten-ing over the last 88 years?;Medicinal Chemistry Research;2023-06-15